Prof. Hee Tae, KIM

Hanyang University College of Medicine, Korea (South)

Email: kimht@hanyang.ac.kr

Qualifications

1997 Ph.D., Hanyang University, Postgraduate School of Medicine

1993 Bachelor of Medicine, Hanyang University, Postgraduate School of Medicine

1987 Medical Doctor, Hanyang University, College of Medicine

Publications (Selected)

1. Koh SH, Park CY, Kim MK, Lee KY, Kim J, Chang DI, Kim SH, Kim HT. Microbleeds and free active MMP-9 are independent risk factors for neurological deterioration in acute lacunar stroke. Eur J Neurol. 2010 Jun 11.
2. Jeong BH, Jeon YC, Lee YJ, Cho HJ, Park SJ, Chung DI, Kim J, Kim SH, Kim HT, Choi EK, Choi KC, Carp RI, Kim YS. Creutzfeldt-Jakob disease with the V203I mutation and M129V polymorphism of the prion protein gene (PRNP) and a 17 kDa prion protein fragment. Neuropathol Appl Neurobiol. 2010 May 20.
3. SC Chung, MH Choi, SJ Lee, JS Choi, BY Lee, SW Moon, HJ Kim, BS Lee, HT Kim, GR Tack. Correlation between psychological factors and the cerebellar volume of normal young adults, International Journal of Clinical and Health Psychology volume 10, number 1, January 2010.
4. Koh SH, Kim SH, Kim HT. Role of glycogen synthase kinase-3 in l-DOPA-induced neurotoxicity. Expert Opin Drug Metab Toxicol. 2009 Nov; 5(11): 1359-68. Review.
5. Kim JS, Shim YS, Song IU, Yoo JY, Kim HT, Kim YI, Lee KS. Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease. Parkinsonism Relat Disord. 2009 Feb 27.
6. Park IS, Song IU, Lee SB, Lee KS, Kim HT, Kim JS. Mirror movements and involuntary homolateral limb synkinesis in a patient with probable Creutzfeldt-Jakob disease. Clin Neurol Neurosurg. 2009 May; 111(4): 380-3.
7. Koh SH, Song C, Noh MY, Kim HY, Lee KY, Lee YJ, Kim J, Kim SH, Kim HT. Inhibition of glycogen synthase kinase-3 reduces l-DOPA-induced neurotoxicity Toxicology. 2008 Feb 26.
8. Kim JS, Lee KS, Song IU, Kim YI, Kim SH, You IR, Kim HT. Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. J Neurol Sci. 2008 Mar 29.
9. Chew NK, Mir P, Edwards MJ, Cordivari C, Martino D, Schneider SA, Kim HT, Quinn NP, Bhatia KP: The natural history of Unverricht-Lundborg disease: a report of eight genetically proven cases. Mov Disord. 2008 Jan; 23(1): 107-13.
10. Song IU, Kim JS, Kim HT, Lee KS. Task-specific focal hand dystonia with usage of a spoon. Parkinsonism Relat Disord. 2008; 14(1): 72-4.
11. Kim JS, An JY, Lee KS, Kim HT: Cooling can relieve the difficulty of playing the tuba in a patient with embouchure dystonia. Mov Disord. 2007 Nov 15; 22(15): 2291-2.
12. Kim HT, Edwards MJ, Tyson J, Quinn NP, Bitner-Glindzicz M, Bhatia KP: Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice-site mutation in the deafness/dystonia peptide gene. Mov Disord. 2007 Jul 15; 22(9): 1328-31.
13. Kim JS, Lee KS, Lim SC, Ahn JY, Song IU, Kim YI, Kim BS, Kim HT: Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment. Mov Disord. 2007 May 15; 22(7): 1043-6.
14. Kim JS, Lee PH, Lee KS, Park JW, Kim YI, Chung YA, Kim SH, Kim SH, Kim J, Choi YY, Kim HT. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism. Mov Disord. 2006 Nov; 21(11): 1990-4.
15. Kim JS, Park JW, Kim YI, Han SJ, Kim HT, Lee KS. Tremors associated with an inferior olivary lesion that developed after a pontine hemorrhage. Mov Disord. 2006 Sep; 21(9): 1539-40.
16. Kim JS, Park JW, Chung SW, Kim YI, Kim HT, Lee KS. Pisa syndrome as a motor complication of Parkinson's disease. Parkinsonism Relat Disord. 2007 Mar; 13(2): 126-8.
17. Kim JS, Park JW, Kim WJ, Kim HT, Kim YI, Lee KS. Disappearance of essential tremor after frontal cortical infarct. Mov Disord. 2006 Aug; 21(8): 1284-5.
18. Kim YS, Lee KY, Koh SH, Park CY, Kim HY, Lee YJ, Kim HT, Kim J, Kim MH, Kim KS, Chang DI, Kim SH. The role of matrix metalloproteinase 9 in early neurological worsening of acute lacunar infarction. Eur Neurol. 2006; 55(1): 11-5.
19. Koh SH, Lee SM, Kim HY, Lee KY, Lee YJ, Kim HT, Kim J, Kim MH, Hwang MS, Song C, Yang KW, Lee KW, Kim SH, Kim OH. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci Lett. 2006 Mar 6; 395(2): 103-7.
20. Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba JP, Ulmer H, Pellecchia MT, Barone P, Kim HT, Hooker J, Quinn NP, Cardozo A, Tolosa E, Abele M, Klockgether T, Ostergaard K, Dupont E, Schimke N, Eggert KM, Oertel W, Djaldetti R, Poewe W; the European MSA Study Group. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord. 2006 Feb; 21(2): 179-86.
21. Geser F, Seppi K, Stampfer-Kountchev M, Kllensperger M, Diem A, Ndayisaba JP, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa MM, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias CJ, Fowler C, Wood N, Quinn N, Widner H, Nilsson CF, Lindvall O, Schimke N, Eggert KM, Oertel W, del Sorbo F, Carella F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, Poewe W, Wenning GK. EMSA-SG: The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm. 2005 Dec; 112(12): 1677-86.
22. Koh SH, Chang DI, Kim HT, Kim J, Kim MH, Kim KS, Bae I, Kim H, Kim DW, Kim SH. Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model Toxicology. 2005 Oct 15; 214(1-2): 131-9.